Related Experiment Videos
Craniosynostosis and related limb anomalies
A O Wilkie1, M Oldridge, Z Tang
1Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK.
Novartis Foundation Symposium
|March 30, 2001
Summary
Genetic mutations in FGFR and MSX2 genes cause craniosynostosis and limb anomalies. Different mutation types lead to distinct developmental effects, impacting cranial suture and limb morphogenesis through altered signaling pathways.
Area of Science:
- Genetics
- Developmental Biology
- Molecular Biology
Background:
- Craniosynostosis syndromes often present with limb anomalies, suggesting shared developmental pathways.
- Mutations in FGFR1, FGFR2, FGFR3, TWIST, and MSX2 are implicated in craniosynostosis.
- Understanding the distinct effects of loss- and gain-of-function mutations is crucial for elucidating pathophysiology.
Purpose of the Study:
- To investigate the pathophysiology of craniosynostosis and limb anomalies using clinical and molecular analysis.
- To explore the contrasting effects of loss- and gain-of-function mutations in key developmental genes.
- To analyze the role of FGFR2 splice forms in Apert syndrome and common mechanisms in FGFR-associated craniosynostosis.
Main Methods:
- Clinical and molecular analysis of patients with craniosynostosis syndromes.
- Biochemical studies to investigate the function of FGFR2 splice forms.
- DNA binding studies to assess the functional impact of MSX2 mutations.
Main Results:
- Apert syndrome mutations in FGFR2 (Ser252Trp, Pro253Arg) exhibit differential effects on cranial and limb development, suggesting distinct mechanisms.
- Alternative splice forms of FGFR2 may mediate these differential effects.
- Gain-of-function mutations in FGFR1, FGFR2, and FGFR3 are associated with craniosynostosis, potentially via prolonged signaling.
- Loss-of-function MSX2 mutations cause parietal foramina, while gain-of-function mutations are linked to craniosynostosis.
Conclusions:
- Cranial suture and limb development share components, with genetic mutations impacting both.
- FGFR and MSX2 mutations have diverse functional consequences, leading to distinct craniofacial and limb phenotypes.
- Understanding mutation-specific effects is key to deciphering the molecular basis of these developmental disorders.